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Abstract
Background: Calculus pyonephrosis is difficult to manage. The aim of this study is to explore the value of a patented
suctioning sheath assisted minimally invasive percutaneous nephrolithotomy (MPCNL) in the treatment of
calculus pyonephrosis.
Methods: One hundred and eighty two patients with calculus pyonephrosis were randomizely divided into
observation group (n = 91) and control group (n = 91). The control group was treated with MPCNL traditionally using
peel-away sheath while the observation group was treated with MPCNL using the patented suctioning sheath.
Results: All the patients in the observation group underwent one stage surgical treatment, 14 patients in the control
group underwent first-stage surgery with the rest of the group underwent one stage surgery. The complication rate
was 12.1% in the observation group, significantly lower than the rate in the control group which was 51.6%;
One surgery stone clearance in the observation group was 96.7% while it was 73.6% in the control group;
operative time in the observation group was (54.5 ± 14.5) min, compared to (70.2 ± 11.7) min in the control
group; the bleeding amount in the observation group was (126.4 ± 47.2) ml, compared to (321.6 ± 82.5) ml in
the control group; the hospitalization duration for the observation group was (6.4 ± 2.3) days, compared to
(10.6 ± 3.7) days in the control group. Comparison of the above indicators, the observation group was better
than the control group with significant difference (p < 0.001 each).
Conclusions: Minimally invasive percutaneous nephrolithotomy with the aid of the patented suctioning sheath in the
treatment of calculus pyonephrosis in one surgery is economic, practical, and warrants clinical promotion.
Trial registration: This study was registered with Chinese Clinical Trial Registry on May 18, 2016 (retrospective
registration) with a trial registration number of ChiCTR-IOR-16008490.
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Background
Currently MPCNL has become one of the most import-
ant means in the treatment of upper urinary calculi.
However, inappropriate infusion or poor drainage both
can lead to significantly increased renal pelvic pressure,
resulting in renal damage at various degrees, liquid
reflux or extravasation, infection spread, urosepsis, or in-
fectious shock. Patients undergo surgeries for compli-
cated stones with pyonephrosis are more liable to
worsening infection and urosepsis [1]. We designed a
patented system with suctioning ability to facilitate min-
imally invasive PCNL (MPCNL). This patented system
was found to be safe and highly efficient in managing
renal stones in the previous study [2–4]. However, we
did not know the success and complication rates of our
MPCNLs in treating renal calculus complicated by pyo-
nephrosis by one surgery. In this study, we performed
one-stage MPCNLs using a self-designed and patented
suctioning lithotripsy sheath [4] (thereafter referred to as
the patent sheath, see Fig. 1) in treating renal and upper
ureteral calculi complicated by pyonephrosis in 91 cases
to clear stone by one surgery, avoided two stage surger-
ies including first-stage percutaneous nephrostomy and




From March 2011 to April 2013 one hundred eighty two
patients with calculus pyonephrosis were admitted and
treated at Ganzhou Hospital of Nanchang University,
China. Among them 110 were males while 72 were fe-
males. The age ranged from 21 to 82 years old with a
mean age at 44.1 ± 3.7 years old. There were 98 cases
with left renal calculus while 84 cases with right renal
calculus. Calculus dimension ranged from 8.8 to
22.5 cm2 with a mean dimension at 15.1 ± 6.5 cm2. All
patients had costovertebral angle (CVA) tenderness by
physical exam. Urinalysis revealed white blood cell
(WBC) ++ ~ +++. Seventy four patients were found to
have Temperature ≥ 37.8 °C. The stone diseases were
diagnosed by B ultrasonography, KUB (Kidneys, ureters,
and bladder x-ray), or intravenous urography (IVU).
Computed tomography (CT) scan was performed for each
patient to confirm. Patients with systemic coagulopathy
were ruled out from the study. These enrolled patients
were randomized into either control group(n = 91) or ob-
servation group(n = 91) in a ratio of 1:1 according to the
random number table. As shown in Table 1, comparisons
of the two groups on sex, age, stone location, and course of
disease revealed no significant difference (P > 0.05 each).
Surgical procedure
Surgery was performed under general anesthesia for all
182 patients, all the surgeries were performed by one
surgeon. Patients in the observation group underwent
patented sheath assisted MPCNL. Patients in the control
group were treated using traditional MPCNL without
the assistance of the patented sheath but peel-away
sheath. Patients in both groups were administered anti-
biotic pre and post surgery. The patient was first placed
Fig. 1 Patented suctioning lithotripsy sheath






Age (year) 43.5 ± 2.9 44.1 ± 3.2 >0.05
Sex
Male: Female 53:38 51:40 >0.05
BMI(kg/cm2) 21.6 ± 5.7 22.5 ± 1.1 >0.05
Stone size(mm) 16.7 ± 5.8 15.1 ± 6.3 >0.05
Stone location >0.05
Renal pelvis and upper segment
of ureter
27 (29.7%) 29 (31.9%)
Upper renal calyx 25 (27.5%) 21 (23.1%)
Mid renal calyx 9 (9.9%) 7 (7.7%)
Lower renal calyx 30 (33.0%) 34 (37.4%)
Renal insufficiency (n,%) 8 (8.8%) 11 (12.1%) >0.05
H/o ESWL (n,%) 15 (14.3%) 17 (12.8%) >0.05
H/o surgery to remove stone (n,%) 13 (14.3%) 14 (15.4%) >0.05
Comorbidities >0.05
Hypertension 7 (7.7%) 6 (6.6%)
Diabetes mellitus 4 (4.4%) 6 (6.6%)
Heart disease 5 (5.5%) 3 (3.3%)
Stone composition >0.05
Calcium oxalate 44 (48.4%) 43 (47.3%)
Calcium phosphate 11 (12.1%) 15 (16.5%)
Cystine 2 (2.2%) 1 (1.1%)
Struvite 19 (20.9%) 17 (18.7%)
Uric acid 7 (7.7%) 5 (5.5%)
Mixed 8 (8.8%) 10 (11.0%)
Hydronephrosis >0.05
Mild 13 (14.3%) 17 (18.7%)
Moderate 47 (51.6%) 49 (53.8%)
Severe 31 (34.1%) 25 (27.5%)
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in a lithotomy position. A 5 F ureteral catheter was then
inserted retrogradely into the renal pelvis through cyst-
oscopy or ureteroscopy, and continuous infusion of sa-
line was used to produce artificial hydronephrosis. After
this, a Foley catheter was inserted; the patient was then
changed to the prone position. Ultrasonography-guided
percutaneous punctures were made with an 18-gauge
coaxial needle into the targeted calyx. The puncture
point was in the 11th intercostal space or the 12 th sub-
costal margin, between the posterior axillary line and
scapula line. The puncture was judged successful if there
was urine overflow or if it touched a stone. Zebra guide-
wire was inserted and fixed. The puncture needle was
then taken out. After a 0.5–0.7 cm skin incision, the
dilation of the percutaneous tract was performed serially
over the guidewire with a fascial dilator from 8 F to
16 F. A 16 F patented sheath was then placed at the per-
cutaneous access port and was connected to a vacuum
aspiration machine. The pressure was maintained at
0.01–0.02 MPa. Subsequently, a small diameter nephro-
scope was inserted through the sheath. Initially, pus or
purulent bolts were sucked out using the vacuum suc-
tioning device (See Fig. 2). A holmium laser was then
used to break the stones, and a vacuum suctioning de-
vice was used to clear gravel through the patented
sheath until complete clearance. We then inspected
renal pelvis and each renal calyx carefully. After finding
that all stones were cleared, we indwelled a 6 F ureteral
stent and a 16 F nephrostomy tube which will be re-
moved 4–5 days after surgery. Occurrence of renal
pelvic perforation was investigated at the end of the
procedure via nephrostogram.
For any patient in the two groups with the following
intraoperative occurrences, the surgery was converted
to a simple nephrostomy: (1) body temperature lower
than 36 °C or higher than 38 °C; (2) heart rate higher
than 90 beats per minute; (3) respiratory rate greater
than 20 breaths per minute or PaCO2 less than
32 mmHg [5]; (4) excessive bleeding;(5) suctioning
channel was blocked due to thick pus.
Observation index
Perioperatively, vital signs were closely monitored.
Also, the complete blood count, serum electrolytes,
BUN/creatinine, and calcitonin were checked. Patients
were evaluated on postoperative day 30 by KUB as-
sess stone-free status. For patients with radiolucent or
residual stones, CT scan was performed. Successful
stone clearance was defined as no residual stone or
residual stone size < 4 mm. Patients in the two groups
were compared for operation time, bleeding amount,
stone clearance rate, complication rate, and average
days of hospitalization.
Statistical analysis
We used Excel for data input. SPSSll.5 statistical software
package was used for data analysis. The measurement data
were represented as mean ± standard deviation (x ±s) and
analyzed using t test. Count data was analyzed using χ2
test. P < 0.05, with statistically significant difference.
Results
All patients in the observation group were treated with
patented sheath assisted MPCNL successfully by one
surgery without major complication including surround-
ing organ injury, pleural effusion, or major bleeding.
There were 75 cases stones were cleared through one
percutaneous tract, 15 cases stones was cleared through
two percutaneous tracts, and two cases stones were
cleared through three percutaneous tracts. There were
ten cases with temperature ≥ 38.5 °C on postoperative
day 2. There was one case in this group with complica-
tion of renal pelvic perforation. For the patients in the
control group, 14 cases underwent first-stage percutan-
eous nephrostomy due to the difficulty in doing litho-
tripsy in the first surgery, while the rest of this group
underwent one stage MPCNL. There were 15 cases with
bleeding ≥ 800 ml and were transfused. There were 25
cases with temperature ≥ 38.5 °C on postoperative day 2.
There were seven cases in this group with complication
of renal pelvic perforation. In the observation group
each index is better than the control group with signifi-
cant difference (P < 0.001 each, see Table 2). Body tem-
peratures returned to normal for those patients with
Fig. 2 Endoscopic view of renal calculus complicated
by pyonephrosis
Huang et al. BMC Urology  (2016) 16:71 Page 3 of 5
postoperative fever after strengthening anti-infection
treatment without the occurrence of sepsis or pyemia.
After a follow up of 3 months, serum creatinine (Scr)
and blood urea nitrogen (BUN) in 74 cases that had
elevated preoperative Scr and BUN preoperatively were
reduced to varying degrees (See Table 2 and Fig. 3).
Discussion
Upper ureter or renal stones often were treated with
MPCNL and most patients can achieve the purpose of
cure. Due to the pressure limit of renal parenchymal re-
flux is 30 mmHg [6], when the MPCNL is performed
under high pressure perfusion it is easy to cause the
intrapelvic pressure over 30 mmHg, and the operation
manipulation, the integrity of the pelvic wall epithelium
could be injured and thereafter leads to direct exposure
of venous and lymphatic system followed by renal paren-
chyma reflux [7]; When the stones and infection occur
at the same time, tissue edema and congestion are more
likely to cause pelvic fluid absorption. A large amount of
short-term liquid absorption can cause the perfusion
fluid syndrome, and when the bacteria and its toxin
reflux into the blood, complications like bacteremia,
sepsis, or postoperative fever occur [8]. MPCNL surgery
complication is related to the amount of liquid absorp-
tion. It is a positive correlation between the integrity of
the epithelial cells, renal pelvic pressure, and the oper-
ation time [6, 9]. Performing MPCNL through irrigation
can cause stones shift. When the collection system is
connected to the renal abscess pus, due to the blurring
of vision, it is not easy to find the pelvic outlet so the
surgeon is often forced to abandon stone lithotripsy in
which circumstance usually a percutaneous nephrost-
omy is performed as a first-stage surgery. In the current
study, incidence rate of surgical complications in the
control group was 51.6%% with 14 cases needing two
staged operation. Therefore, how to improve success
rate of surgery and reduce postoperative complications
for calculus pyonephrosis is always a challenge in the
field of Urology [10].
According to a previous report, when the intra-pelvic
pressure is below 20 mmHg, it is feasible to use the
EMS LithoClast master for one-phase PCNL of the rela-
tively symptomatically stable patients with calculous
pyonephrosis. Nevertheless, this surgical procedure has
always carried high risks and its advantages and disad-
vantages should be validated by further studies of larger
sample sizes [11, 12]. Patented sheath connected during
surgery remains 0.01–0.02 MPa negative pressure suc-
tion to keep renal pelvis in a negative pressure state, so
that the discharge of perfusion fluid and pus went
smoothly, avoided lavage, bacteria, toxins reflux and
spread to surrounding tissues, reduced fever infection
complications after surgery. In the current study, only
10 patients in the observation group were found to have
temperature ≥ 38.5 °C, significantly lower than those in
the control group; Negative pressure adsorption can re-
move the effect of blood clots and floc, the vision can be
more clear. With negative pressure “adsorption” effect
on the gravel, small stones and pus hidden in the calyces
can be automatically removed by suction. Due to a big







Operation time (min) 54.5 ± 14.5 70.2 ± 11.7 <0.001
Bleeding amount (ml) 126.4 ± 47.2 321.6 ± 82.5 <0.001
Stone-free rates 96.7% (88) 73.6% (67) <0.001
Incidence of complication
Fever≥ 38.5 °C 10 25 <0.001
Bleeding amount≥ 800 ml 0 15 <0.001
Renal pelvic perforation 1 7 <0.001
Days for hospitalization 6.4 ± 2.3 10.6 ± 3.7 <0.001
Fig. 3 Left: Preoperative KUB for a patient with staghorn renal calculus complicated by pyonephrosis; Middle: Preoperative IVU for a patient with
staghorn renal calculus complicated by pyonephrosis; Right: Post-MPCNL KUB for a patient with staghorn renal calculus complicated by pyonephrosis,
with the aid of the patented suctioning sheath
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discharge cavity of the sheath which is not easy to be
blocked, there is no need of lithotomy forceps or stone
basket, without the need for repeated importing a ure-
teroscope to flush, either. We are thus able to improve
the efficacy of lithotripsy and stone clearance, shorten
operation time, and reduce the operation complications
such as bleeding [3]. In this study, all patients in the ob-
servation group were successfully treated with the
MPCNL by one surgery with a stone clearance rate of
96.7%. There were no adjacent organ injury and major
bleeding, compared with the control group, with signifi-
cant difference. With improved success rate of surgery
and reduced rate of complication, the hospitalization
time was shortened and the cost of hospitalization was
reduced. Of course, surgeons may have been more ag-
gressive using the patented sheath and less aggressive
with the peel-away sheath due to the aims of this study,
therefore getting higher stone-free rates in patients in
the observation arm. Other limitation of this study is
that we did not measure intrarenal pelvic pressure for
every patient during the surgery, even though we have
had previous research data revealing that the patented
sheath could reduce intrarenal pressure.
Conclusion
In summary, through analysis and comparison the obser-
vation group was better than the control group reflected
by multiple clinical indexes. Managing calculus pyone-
phrosis using patented sheath assisted MPCNL is safe,
economic with fewer complications.
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